Follow-up study for the KOI2-002 study in epidermolysis bullosa patients
Phase 2
Completed
- Conditions
- Dystrophic epidermolysis bullosa
- Registration Number
- JPRN-jRCT2080224722
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Patients with dystrophic epidermolysis bullosa who participated in the KOI2-002 study and received KOI2 treatment.
Exclusion Criteria
Patients who are considered inappropriate for the study by the investigator or subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method